Iovance Biotherapeutics
0 sources
Financials
0001104659-26-018899Iovance Biotherapeutics
Summary
Iovance Biotherapeutics is a business[1]. It ranks in the top 4% of business entities by monthly Wikipedia readership (82 views/month).[2]
Key Facts
- Iovance Biotherapeutics is in the country of United States[3].
- Iovance Biotherapeutics is in the country of US[4].
- Iovance Biotherapeutics's instance of is recorded as business[5].
- Iovance Biotherapeutics's instance of is recorded as public company[6].
- Iovance Biotherapeutics's headquarters location is recorded as San Carlos[7].
- Iovance Biotherapeutics's stock exchange is recorded as Nasdaq[8].
- Iovance Biotherapeutics's industry is recorded as pharmaceutical industry[9].
- 2007 marks the founding of Iovance Biotherapeutics[10].
- 2017-06-01 marks the founding of Iovance Biotherapeutics[11].
- Iovance Biotherapeutics's official website is recorded as http://www.iovance.com/[12].
- Iovance Biotherapeutics's legal form is recorded as XTIQ[13].
Product Details
The following facts are restated verbatim from public-domain and CC0 open-data sources — every line is independently verifiable against the named source's catalog.
GLEIF Golden Copy — Level 1 entity data
-
Legal Entity Identifier (LEI): 2549002L8WT2ACU5Q878[14]
-
Registered legal name: Iovance Biotherapeutics, INC.[15]
-
Legal jurisdiction: US-DE[16]
-
GLEIF entity category: GENERAL[17]
-
Legal form (ISO 20275 ELF): XTIQ[18]
-
Entity status: ACTIVE[19]
-
LEI registration status: ISSUED[20]
-
Entity created: 2017-06-01[21]
-
LEI first registered: 2023-04-21[22]
-
LEI last updated: 2026-02-19[23]
-
LEI next renewal: 2027-02-21[24]
-
Managing LOU: 5493001KJTIIGC8Y1R12[25]
-
Registration authority: RA000602[26]
-
Authority entity ID: 6431490[27]
-
Conformity flag: NON_CONFORMING[28]
Body
Founding
Recorded inception include 2007[10] and 2017-06-01[11].
Operations
Iovance Biotherapeutics's headquarters location is recorded as San Carlos[7].
Industry
Iovance Biotherapeutics's industry is recorded as pharmaceutical industry[9].
Ownership
Iovance Biotherapeutics's stock exchange is recorded as Nasdaq[8].
Why It Matters
Iovance Biotherapeutics ranks in the top 4% of business entities by monthly Wikipedia readership (82 views/month).[2]